G6PD and COVID-19: An ex vivo study from the same Asian population established that immune cells (monocytes) from G6PD patients were at a higher risk of viral infections [59] and recent studies have linked G6PD deficiency with susceptibility to coronavirus (COVID-19) [60, 61].